Mein Warenkorb

Nectin-1

Nectin-1 Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (2)

  • Etikett

    His Tag (1)Fc Tag (1)

  • Marker

    Unconjugated (2)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
PV1-H5223
Human
HEK293
Human Nectin-1 / PVRL1 / CD111 Protein, His Tag
In den Warenkorb legen
PV1-H5253
Human
HEK293
Human Nectin-1 / PVRL1 / CD111 Protein, Fc Tag
In den Warenkorb legen
Gesamtmenge2
  • 1

Nectin-1 Molekülhintergrund

Poliovirus receptor-related protein 1 (PVRL1) is also known as Herpes virus entry mediator C (HveC), Herpesvirus Ig-like receptor (HIgR), Nectin-1, CD antigen CD111, PVRL1 / Nectin-1 / CD111 belongs to the nectin family. PVRL1 / Nectin-1 is a membrane protein with three extracellular immunoglobulin domains, a single transmembrane helix and a cytoplasmic tail. The protein can mediate Ca2+-independent cellular adhesion further characterizing it as IgSF cell adhesion molecule (IgSF CAM). PVRL1 is adhesion molecule found in a wide range of tissues. PVRL1 / Nectin-1 promotes cell-cell contacts by forming homophilic or heterophilic trans-dimers. Heterophilic interactions have been detected between PVRL1/nectin-1 and PVRL3/nectin-3 and between PVRL1/nectin-1 and PVRL4/nectin-4.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Vitamin E/Ascorbic AcidPhase 3 ClinicalAdvanced Medical ProjectsFragile X Syndrome; Neuralgia
Details
Lidocaine/Allantoin/Glycyrrhetinic Acid/Vitamin EPhase 2 ClinicalHemorrhoids; Pain; Warts; Fissure in Ano
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Crotamiton/Diphenhydramine Hydrochloride/Vitamin E/Glycyrrhetinic AcidApproved安夫康Dermatitis
Details
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns